Arcellx (ACLX) Earnings Date & Reports

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ACLX is expected to report earnings to fall 12.85% to -75 cents per share on May 08

Q1'25

Est.

$-0.76

Q4'24

Missed

by $0.31

Q3'24

Missed

by $0.14

Q2'24

Beat

by $0.01

Q1'24

Beat

by $0.37

The last earnings report on February 27 showed earnings per share of -87 cents, missing the estimate of -55 cents. With 295.95K shares outstanding, the current market capitalization sits at 3.51B.

View a ticker or compare two or three

Compare

ACLX